As the U.S. grapples with a flu season that has killed 21 people so far, the Food and Drug Administration on Tuesday cleared the way for greater use of a molecular test designed to quickly detect the presence of the virus in a nasal swab.
FDA clears wider use of rapid test for influenza
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.